Welcome back, everyone. We're going to resume the meeting with our second panel.
Welcome to our witnesses. We have with us, as an individual, Mr. Stephen Aplin. Welcome, Stephen.
From the Canadian Nuclear Laboratories, we have Eric McGoey, vice-president, corporate affairs.
I think you may have both been in the room when you heard the rules of the road here. Please address your remarks through the chair. You may have noticed I'm a little loose on the rules from time to time, just to encourage good dialogue between our members and yourselves.